Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.75 GBX | +1.43% | -22.83% | -74.64% |
Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
Apr. 25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
Sales 2023 | 832K 1.04M | Sales 2024 * | 800K 999K | Capitalization | 16.92M 21.13M |
---|---|---|---|---|---|
Net income 2023 | -5M -6.25M | Net income 2024 * | -5M -6.25M | EV / Sales 2023 | 80.2 x |
Net cash position 2023 * | 7.07M 8.83M | Net cash position 2024 * | 1.93M 2.41M | EV / Sales 2024 * | 18.7 x |
P/E ratio 2023 |
-11.3
x | P/E ratio 2024 * |
-2.91
x | Employees | 24 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.35% |
Latest transcript on Destiny Pharma plc
1 day | +1.43% | ||
1 week | -22.83% | ||
Current month | -30.39% | ||
1 month | -30.39% | ||
3 months | -73.11% | ||
6 months | -64.50% | ||
Current year | -74.64% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 23-08-31 | |
William Love
FOU | Founder | 62 | 96-03-03 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 11-08-31 |
William Love
FOU | Founder | 62 | 96-03-03 |
Nigel Brooksby
BRD | Director/Board Member | - | 22-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 17.75 | +1.43% | 478,387 |
24-04-29 | 17.5 | +7.69% | 1,267,079 |
24-04-26 | 16.25 | -2.99% | 1,536,814 |
24-04-25 | 16.75 | -22.09% | 7,411,936 |
24-04-24 | 21.5 | -2.27% | 184,683 |
Delayed Quote London S.E., April 30, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-74.64% | 20.93M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- DEST Stock